Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Leap Therapeutics Inc
LPTXCurrent price
0.37 USD
-0.0008 USD (-0.22%)
Last closed
0.36 USD
Company
www.leaptx.com
ISIN
US52187K1016
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
17 073 074 USD
Yield for 12 month
-85.05 %
1Y
3Y
5Y
10Y
15Y
LPTX
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts. Address: 47 Thorndike Street, Cambridge, MA, United States, 02141
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-427 000 USD
Current Quarter
–
Last Quarter
–
Key Figures LPTX
1 year
3 years
5 years
10 years
EBITDA
-70 052 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-71.81 %
PEG Ratio
0.75
Return On Equity TTM
-142.43 %
Wall Street Target Price
3.00 USD
Revenue TTM
375 000 USD
Book Value
0.91 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
1 500 000 USD
Earnings per share
-1.67 USD
Diluted Eps TTM
-1.67 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LPTX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History LPTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:10
Payout Ratio TTM
–
Last Split Date
21.06.2023
Stock Valuation LPTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.90
Price Sales TTM
160.10
Enterprise Value EBITDA
0.47
Price Book MRQ
0.82
Financials LPTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LPTX
For 52 weeks
0.22 USD
4.79 USD
50 Day MA
0.37 USD
Shares Short Prior Month
3 461 617
200 Day MA
1.92 USD
Short Ratio
3.73
Shares Short
2 207 535
Short Percent
6.25 %
BeatStart